228 Braf inhibitors, sb590885 and dabrafenib, enhance erk1/2 signalling in cardiomyocytes and promote cardiac hypertrophy | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Basic Science

228 Braf inhibitors, sb590885 and dabrafenib, enhance erk1/2 signalling in cardiomyocytes and promote cardiac hypertrophy

Free

Online download statistics by month:

Online download statistics by month: June 2017 to February 2023

	Abstract	Full	Pdf
Jun 2017	23	0	11
Jul 2017	28	0	4
Aug 2017	24	0	3
Sep 2017	14	0	0
Oct 2017	20	0	3
Nov 2017	24	0	4
Dec 2017	30	0	3
Jan 2018	34	0	1
Feb 2018	26	0	3
Mar 2018	19	0	1
Apr 2018	44	0	2
May 2018	17	0	1
Jun 2018	34	0	1
Jul 2018	90	0	17
Aug 2018	30	0	3
Sep 2018	28	0	2
Oct 2018	34	0	2
Nov 2018	18	0	1
Dec 2018	30	0	1
Jan 2019	14	0	0
Feb 2019	20	0	3
Mar 2019	8	0	4
Apr 2019	24	0	3
May 2019	16	0	5
Jun 2019	22	0	2
Jul 2019	44	0	3
Aug 2019	30	0	5
Sep 2019	4	0	2
Oct 2019	18	0	3
Nov 2019	12	0	6
Dec 2019	12	0	1
Jan 2020	23	0	1
Feb 2020	14	0	4
Mar 2020	0	0	2
Apr 2020	23	0	7
May 2020	19	0	3
Jun 2020	6	0	2
Jul 2020	8	0	1
Aug 2020	8	0	3
Sep 2020	46	0	17
Oct 2020	12	0	2
Nov 2020	6	0	2
Dec 2020	14	0	7
Jan 2021	20	0	13
Feb 2021	27	0	10
Mar 2021	12	0	8
Apr 2021	44	0	16
May 2021	3	0	2
Jun 2021	0	0	1
Jul 2021	0	0	5
Aug 2021	0	0	1
Sep 2021	0	0	5
Oct 2021	11	0	20
Nov 2021	11	0	13
Dec 2021	11	0	3
Jan 2022	5	0	1
Feb 2022	10	0	0
Mar 2022	15	0	3
Apr 2022	0	0	1
May 2022	16	0	7
Jun 2022	14	0	3
Jul 2022	9	0	0
Aug 2022	22	0	6
Sep 2022	24	0	8
Oct 2022	13	0	5
Nov 2022	6	0	6
Dec 2022	14	0	1
Jan 2023	10	0	0
Feb 2023	16	0	3
Total	1283	0	292